118 related articles for article (PubMed ID: 3162139)
21. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
David C; Chaste A; Saison C; Combremont AG
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735
[TBL] [Abstract][Full Text] [Related]
22. Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
Sullam PM; Täuber MG; Hackbarth CJ; Chambers HF; Scott KG; Sande MA
Antimicrob Agents Chemother; 1985 May; 27(5):685-7. PubMed ID: 3860185
[TBL] [Abstract][Full Text] [Related]
23. [Susceptibility to selected coagulase-negative chemotherapeutic agents of methicillin resistant staphylococci isolated from clinical materials in 1997-1998].
Kochman M; Fordymacki P; Ławrynowicz-Paciorek M; Kałuzewski S; Meszaros J; Połowniak-Pracka H; Magdziak A; Sztandar-Sztanderska M
Med Dosw Mikrobiol; 2000; 52(4):341-52. PubMed ID: 11286176
[TBL] [Abstract][Full Text] [Related]
24. [In vitro activity of roxithromycin compared to 5 other macrolides against staphylococci].
Brun Y; Coulet M; Forey F; Fleurette J
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):613-8. PubMed ID: 3054736
[TBL] [Abstract][Full Text] [Related]
25. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Vuye A
Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
[TBL] [Abstract][Full Text] [Related]
26. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Clarke AM; Zemcov SJ; Campbell ME
J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112
[TBL] [Abstract][Full Text] [Related]
27. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
[TBL] [Abstract][Full Text] [Related]
28. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
Rahal K
Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
[TBL] [Abstract][Full Text] [Related]
29. [Susceptibility to quinolones of Salmonella isolated from men and animals].
Avril JL; Couete I; Travert MF; Autuly F; Plessis P
Pathol Biol (Paris); 1995 Apr; 43(4):270-3. PubMed ID: 7567113
[TBL] [Abstract][Full Text] [Related]
30. In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs.
Fass RJ; Helsel VL
Antimicrob Agents Chemother; 1987 Oct; 31(10):1457-60. PubMed ID: 3481244
[TBL] [Abstract][Full Text] [Related]
31. [Penicillin-resistance as indicator of resistance of Staphylococcus aureus towards cephalosporines and structure-related substances (author's transl)].
Hirschl A; Stanek G; Rotter M
Zentralbl Bakteriol A; 1981 Feb; 248(4):463-8. PubMed ID: 6784390
[TBL] [Abstract][Full Text] [Related]
32. [Susceptibility of methicillin-sensitive and methicillin-resistant staphylococci to ciprofloxacin].
Namysł E; Piechowicz L; Krzywińska E; Galiński J
Med Dosw Mikrobiol; 1993; 45(2):149-52. PubMed ID: 8309287
[TBL] [Abstract][Full Text] [Related]
33. In vitro antimicrobial interactions of arthemeter with some 4-quinolones.
Esimone CO; Adikwu MU; Nwafor SV; Okoli CO; Ndu OO; Nwoke OI
Boll Chim Farm; 2002; 141(5):385-8. PubMed ID: 12481382
[TBL] [Abstract][Full Text] [Related]
34. New trends in the chemotherapy of staphylococcal infections.
Russo G; Tempera G; Stefani S; Nicoletti G
Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
[TBL] [Abstract][Full Text] [Related]
35. [Resistance of Staphylococcus aureus to methicillin].
Roncoroni AJ; Schuster M; Bianchini HM; Damiano C
Rev Argent Microbiol; 1983; 15(4):227-31. PubMed ID: 6400769
[TBL] [Abstract][Full Text] [Related]
36. In vitro study of staphylococci susceptibility to gatifloxacin.
Tuchiluş C; Poiată A; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):516-9. PubMed ID: 17983195
[TBL] [Abstract][Full Text] [Related]
37. Virulence of genus Staphylococcus. III. Studies on the pathogenicity to mice.
Furusawa K; Miyoshi Y
Bull Tokyo Med Dent Univ; 1975 Mar; 22(1):1-8. PubMed ID: 47790
[TBL] [Abstract][Full Text] [Related]
38. In vitro antibacterial activity of norfloxacin (MK-0366).
King A; Warren C; Shannon K; Phillips I
Antimicrob Agents Chemother; 1982 Apr; 21(4):604-7. PubMed ID: 6211139
[TBL] [Abstract][Full Text] [Related]
39. [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
Cantet P; Renaudin H; Quentin C; Bebear C
Pathol Biol (Paris); 1983 Jun; 31(6):501-3. PubMed ID: 6224125
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of l-ofloxacin against norfloxacin-resistant coagulase-negative staphylococci.
Foleno B; Fu KP
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):557-9. PubMed ID: 1330420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
